MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMC 4373420)

Published in Schizophr Res on August 02, 2010

Authors

Albert H Kim1, Mark Reimers, Brion Maher, Vernell Williamson, Omari McMichael, Joseph L McClay, Edwin J C G van den Oord, Brien P Riley, Kenneth S Kendler, Vladimir I Vladimirov

Author Affiliations

1: Virginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Medical College of Virginia of Virginia Commonwealth University, Richmond, VA 23298-0424, USA.

Articles citing this

MicroRNAs in neuronal function and dysfunction. Trends Neurosci (2012) 1.94

miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res (2012) 1.76

Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression. Biol Psychiatry (2014) 1.54

Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev (2013) 1.52

MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci U S A (2012) 1.49

MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One (2011) 1.47

Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. Schizophr Res (2012) 1.32

HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs. J Biol Chem (2011) 1.28

Functions of noncoding RNAs in neural development and neurological diseases. Mol Neurobiol (2011) 1.27

MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS One (2012) 1.25

The Emerging Role of microRNAs in Schizophrenia and Autism Spectrum Disorders. Front Psychiatry (2012) 1.22

Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J Psychiatr Res (2013) 1.20

Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. J Biol Chem (2011) 1.17

Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients. Transl Psychiatry (2014) 1.15

Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice. PLoS Pathog (2012) 1.10

Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Transl Psychiatry (2012) 1.08

Age-dependent microRNA control of synaptic plasticity in 22q11 deletion syndrome and schizophrenia. J Neurosci (2012) 1.07

Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126. Exp Neurol (2011) 1.04

Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder. Neuropsychopharmacology (2012) 1.04

miRNA-132: a dynamic regulator of cognitive capacity. Brain Struct Funct (2012) 1.02

H3K4 tri-methylation in synapsin genes leads to different expression patterns in bipolar disorder and major depression. Int J Neuropsychopharmacol (2012) 1.02

MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction. Neurobiol Dis (2012) 1.02

In vivo microRNA detection and quantitation in cerebrospinal fluid. J Mol Neurosci (2012) 1.02

Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar disorder and depressed subjects. PLoS One (2014) 0.99

Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder. Mol Psychiatry (2015) 0.99

The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders. Front Genet (2012) 0.98

MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients. Neurobiol Dis (2013) 0.97

Potential Impact of miR-137 and Its Targets in Schizophrenia. Front Genet (2013) 0.96

MicroRNAs and Multiple Sclerosis. Autoimmune Dis (2010) 0.94

Evidence demonstrating role of microRNAs in the etiopathology of major depression. J Chem Neuroanat (2011) 0.94

Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions. Am J Transl Res (2013) 0.92

The environmental neurotoxicant PCB 95 promotes synaptogenesis via ryanodine receptor-dependent miR132 upregulation. J Neurosci (2014) 0.87

MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases. Int J Mol Sci (2016) 0.87

Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorder. Transl Psychiatry (2015) 0.87

Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. Front Cell Neurosci (2013) 0.87

Molecular mechanisms of peripheral nerve regeneration: emerging roles of microRNAs. Front Physiol (2013) 0.86

MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del. PLoS One (2015) 0.86

miRNA regulons associated with synaptic function. PLoS One (2012) 0.86

Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine. Psychopharmacology (Berl) (2013) 0.86

Transcriptome profiling of human hippocampus dentate gyrus granule cells in mental illness. Transl Psychiatry (2014) 0.85

Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder. Pharmacol Biochem Behav (2011) 0.85

Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications. Dialogues Clin Neurosci (2014) 0.85

Heterogeneity and individuality: microRNAs in mental disorders. J Neural Transm (Vienna) (2014) 0.84

Maturation of the human dorsolateral prefrontal cortex coincides with a dynamic shift in microRNA expression. Schizophr Bull (2013) 0.84

Mining the 3'UTR of autism-implicated genes for SNPs perturbing microRNA regulation. Genomics Proteomics Bioinformatics (2014) 0.83

Lack of association between microRNA-137 SNP rs1625579 and schizophrenia in a replication study of Han Chinese. Mol Genet Genomics (2014) 0.82

MicroRNA Dysregulation, Gene Networks, and Risk for Schizophrenia in 22q11.2 Deletion Syndrome. Front Neurol (2014) 0.82

Circulating microRNA-144-5p is associated with depressive disorders. Clin Epigenetics (2015) 0.82

MicroRNA as therapeutic targets for treatment of depression. Neuropsychiatr Dis Treat (2013) 0.81

microRNAs as novel biomarkers of schizophrenia (Review). Exp Ther Med (2014) 0.81

Cortical Tubers: Windows into Dysregulation of Epilepsy Risk and Synaptic Signaling Genes by MicroRNAs. Cereb Cortex (2014) 0.80

Targeted deletion of miR-132/-212 impairs memory and alters the hippocampal transcriptome. Learn Mem (2016) 0.80

Association study of H2AFZ with schizophrenia in a Japanese case-control sample. J Neural Transm (Vienna) (2014) 0.80

Transcriptome Profiling of Peripheral Blood in 22q11.2 Deletion Syndrome Reveals Functional Pathways Related to Psychosis and Autism Spectrum Disorder. PLoS One (2015) 0.80

MicroRNA-derived network analysis of differentially methylated genes in schizophrenia, implicating GABA receptor B1 [GABBR1] and protein kinase B [AKT1]. Biol Direct (2015) 0.79

Post-transcriptional regulation of SHANK3 expression by microRNAs related to multiple neuropsychiatric disorders. Mol Brain (2015) 0.79

Epigenetic management of major psychosis. Clin Epigenetics (2011) 0.79

Pluripotent stem cells as a model to study non-coding RNAs function in human neurogenesis. Front Cell Neurosci (2013) 0.79

miR-148b-3p promotes migration of Schwann cells by targeting cullin-associated and neddylation-dissociated 1. Neural Regen Res (2016) 0.79

Circulating miRNAs profiles in tourette syndrome: molecular data and clinical implications. Mol Brain (2015) 0.78

Preliminary investigation of miRNA expression in individuals at high familial risk of bipolar disorder. J Psychiatr Res (2015) 0.78

Integrating mRNA and miRNA Weighted Gene Co-Expression Networks with eQTLs in the Nucleus Accumbens of Subjects with Alcohol Dependence. PLoS One (2015) 0.77

Polymorphisms in MicroRNA Genes And Genes Involving in NMDAR Signaling and Schizophrenia: A Case-Control Study in Chinese Han Population. Sci Rep (2015) 0.77

Traumatic brain injury increases levels of miR-21 in extracellular vesicles: implications for neuroinflammation. FEBS Open Bio (2016) 0.77

Identification of developmentally regulated PCP-responsive non-coding RNA, prt6, in the rat thalamus. PLoS One (2014) 0.76

Genome-wide DNA methylome reveals the dysfunction of intronic microRNAs in major psychosis. BMC Med Genomics (2015) 0.76

Path from schizophrenia genomics to biology: gene regulation and perturbation in neurons derived from induced pluripotent stem cells and genome editing. Neurosci Bull (2015) 0.76

Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue. Transl Psychiatry (2016) 0.76

Preliminary evidence for association of genetic variants in pri-miR-34b/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder. Transl Psychiatry (2016) 0.76

The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression. J Psychiatr Res (2016) 0.75

Bipolar Disorder Associated microRNA, miR-1908-5p, Regulates the Expression of Genes Functioning in Neuronal Glutamatergic Synapses. Exp Neurobiol (2016) 0.75

Expression quantitative trait loci (eQTLs) in microRNA genes are enriched for schizophrenia and bipolar disorder association signals. Psychol Med (2015) 0.75

Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future. Prog Neuropsychopharmacol Biol Psychiatry (2016) 0.75

Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity. Neurotoxicology (2016) 0.75

Double In situ Hybridization for MicroRNAs and mRNAs in Brain Tissues. Front Mol Neurosci (2016) 0.75

A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates. Curr Neuropharmacol (2015) 0.75

Dissecting bipolar disorder complexity through epigenomic approach. Mol Psychiatry (2016) 0.75

The miR-132/212 locus: a complex regulator of neuronal plasticity, gene expression and cognition. RNA Dis (2016) 0.75

The Role of microRNA Expression in Cortical Development During Conversion to Psychosis. Neuropsychopharmacology (2017) 0.75

Articles cited by this

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 82.89

MicroRNA expression profiles classify human cancers. Nature (2005) 69.12

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature (2005) 48.95

miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res (2006) 39.25

Human MicroRNA targets. PLoS Biol (2004) 34.51

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature (2009) 33.26

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet (2008) 32.08

MicroRNA targets in Drosophila. Genome Biol (2003) 23.59

MicroRNA genes are transcribed by RNA polymerase II. EMBO J (2004) 20.65

Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25

Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet (2002) 17.20

Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev (2006) 15.20

Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol (2004) 15.15

Common variants conferring risk of schizophrenia. Nature (2009) 10.37

Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet (2008) 10.19

A brain-specific microRNA regulates dendritic spine development. Nature (2006) 10.18

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 9.23

microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A (2006) 8.24

Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature (2009) 8.12

Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl (1992) 7.04

Whole-genome association study of bipolar disorder. Mol Psychiatry (2008) 6.80

Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells (2005) 6.72

A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A (2005) 6.61

Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet (2007) 5.28

Identification of human microRNA targets from isolated argonaute protein complexes. RNA Biol (2007) 4.96

microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res (2008) 4.81

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet (2004) 4.71

Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis (2008) 3.84

The stanley foundation brain collection and neuropathology consortium. Schizophr Res (2000) 3.37

MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res (2006) 3.36

Systematic identification of microRNA functions by combining target prediction and expression profiling. Nucleic Acids Res (2006) 3.29

microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol (2007) 3.26

RDML: structured language and reporting guidelines for real-time quantitative PCR data. Nucleic Acids Res (2009) 2.72

High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic Acids Res (2008) 2.71

Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci U S A (2009) 2.61

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol (2007) 2.57

Predicting and validating microRNA targets. Genome Biol (2004) 2.54

Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics (2008) 2.50

Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry (2002) 2.43

The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull (1993) 2.40

Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet (2008) 2.33

Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner. J Neurochem (2005) 2.25

Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry (2003) 2.18

Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry (2009) 2.16

Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One (2007) 1.85

MicroRNA function in neuronal development, plasticity and disease. Biochim Biophys Acta (2008) 1.84

Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet C Semin Med Genet (2003) 1.80

Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review. J Psychopharmacol (2007) 1.78

Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull (2001) 1.49

MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11). Biochemistry (Mosc) (2007) 1.41

Investigating the association between cigarette smoking and schizophrenia in a cohort study. Am J Psychiatry (2003) 1.35

AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol Psychiatry (2007) 1.30

Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry (2005) 1.26

Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol Psychiatry (2004) 1.26

Independent diagnoses of adoptees and relatives as defined by DSM-III in the provincial and national samples of the Danish Adoption Study of Schizophrenia. Arch Gen Psychiatry (1994) 1.26

Suicide risk in schizophrenia: learning from the past to change the future. Ann Gen Psychiatry (2007) 1.25

Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia. Mol Psychiatry (2005) 1.15

Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia. Aust N Z J Psychiatry (2007) 1.13

Small RNAs in human brain development and disorders. Biochemistry (Mosc) (2005) 1.07

MicroRNAs in brain function and disease. Curr Neurol Neurosci Rep (2008) 1.07

The NMDA/D1 receptor complex as a new target in drug development. Curr Top Med Chem (2006) 1.04

Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. Am J Med Genet B Neuropsychiatr Genet (2006) 1.03

Gene expression in the etiology of schizophrenia. Schizophr Bull (2008) 0.93

Statistical modeling in case-control real-time RT-PCR assays, for identification of differentially expressed genes in schizophrenia. Biostatistics (2005) 0.93

Genetics of bipolar disorder. Drugs Today (Barc) (2005) 0.90

Analysis of a cluster of polymorphisms in AKT1 gene in bipolar pedigrees: a family-based association study. Neurosci Lett (2003) 0.88

Articles by these authors

High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics (2005) 14.02

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry (2003) 10.44

Spatio-temporal transcriptome of the human brain. Nature (2011) 9.19

Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature (2009) 8.12

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02

Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44

Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63

A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34

Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry (2011) 4.29

Specifying race-ethnic differences in risk for psychiatric disorder in a USA national sample. Psychol Med (2005) 4.05

Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet (2002) 4.03

Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet (2010) 3.91

Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell (2004) 3.72

A population-based twin study of the relationship between neuroticism and internalizing disorders. Am J Psychiatry (2006) 3.48

Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet (2008) 3.33

Personality and comorbidity of common psychiatric disorders. Br J Psychiatry (2005) 3.27

Lifetime risk and persistence of psychiatric disorders across ethnic groups in the United States. Psychol Med (2005) 3.19

MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res (2009) 3.03

A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol Med (2004) 2.98

Age-related changes in heritability of behavioral phenotypes over adolescence and young adulthood: a meta-analysis. Twin Res Hum Genet (2007) 2.94

A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry (2013) 2.93

Association of different adverse life events with distinct patterns of depressive symptoms. Am J Psychiatry (2007) 2.90

Medicine. The future of psychiatric research: genomes and neural circuits. Science (2010) 2.79

Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet (2013) 2.68

Differences in genetic and environmental influences on the human cerebral cortex associated with development during childhood and adolescence. Hum Brain Mapp (2009) 2.56

Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel. Mol Cancer Ther (2006) 2.55

Critical slowing down as early warning for the onset and termination of depression. Proc Natl Acad Sci U S A (2013) 2.54

Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am J Psychiatry (2005) 2.29

Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet (2011) 2.28

A stromal gene signature associated with inflammatory breast cancer. Int J Cancer (2008) 2.18

A pediatric twin study of brain morphometry. J Child Psychol Psychiatry (2006) 2.07

The Internet-based MGS2 control sample: self report of mental illness. Am J Psychiatry (2010) 2.05

The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biol Psychiatry (2005) 2.03

Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res (2008) 2.01

Impact of diagnostic misclassification on estimation of genetic correlations using genome-wide genotypes. Eur J Hum Genet (2012) 2.01

Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids. Addiction (2007) 1.96

Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet (2013) 1.96

Is bereavement-related depression different than non-bereavement-related depression? Psychol Med (2007) 1.94

Risk for psychiatric disorder among immigrants and their US-born descendants: evidence from the National Comorbidity Survey Replication. J Nerv Ment Dis (2007) 1.93

Sex differences in the pathways to major depression: a study of opposite-sex twin pairs. Am J Psychiatry (2014) 1.88

SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell (2011) 1.86

Genetic and family and community environmental effects on drug abuse in adolescence: a Swedish national twin and sibling study. Am J Psychiatry (2014) 1.82

The structure of psychiatric science. Am J Psychiatry (2014) 1.81

The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry (2005) 1.79

Twins and the study of rater (dis)agreement. Psychol Methods (2007) 1.77

An integrative genomic and epigenomic approach for the study of transcriptional regulation. PLoS One (2008) 1.76

Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One (2009) 1.72

Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence. Am J Med Genet B Neuropsychiatr Genet (2009) 1.68

Schizophrenia gene networks and pathways and their applications for novel candidate gene selection. PLoS One (2010) 1.67

Review of twin and family studies on neuroanatomic phenotypes and typical neurodevelopment. Twin Res Hum Genet (2007) 1.67

The Norwegian Institute of Public Health twin study of mental health: examining recruitment and attrition bias. Twin Res Hum Genet (2009) 1.66

A multivariate analysis of neuroanatomic relationships in a genetically informative pediatric sample. Neuroimage (2007) 1.65

Sex differences in the genetic and environmental influences on the development of antisocial behavior. Dev Psychopathol (2002) 1.64

An analytical pipeline for genomic representations used for cytosine methylation studies. Bioinformatics (2008) 1.64

Molecular genetic studies of schizophrenia. Eur J Hum Genet (2006) 1.64

No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science (2002) 1.57

The borderline diagnosis III: identifying endophenotypes for genetic studies. Biol Psychiatry (2002) 1.56

The temporal relationship of the onsets of alcohol dependence and major depression: using a genetically informative study design. Psychol Med (2006) 1.56

A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs. Psychol Med (2004) 1.56

A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case. Bioinformatics (2009) 1.50

Interpretation of interactions: guide for the perplexed. Br J Psychiatry (2010) 1.48

Extensions to the modeling of initiation and progression: applications to substance use and abuse. Behav Genet (2006) 1.48

Medical and psychiatric morbidity in obese women with and without binge eating. Int J Eat Disord (2002) 1.46

Psychiatric disorders: a conceptual taxonomy. Am J Psychiatry (2007) 1.45

The relationship between avoidant personality disorder and social phobia: a population-based twin study. Am J Psychiatry (2007) 1.44

Validity of the bereavement exclusion criterion for the diagnosis of major depressive episode. World Psychiatry (2007) 1.44

Low extraversion and high neuroticism as indices of genetic and environmental risk for social phobia, agoraphobia, and animal phobia. Am J Psychiatry (2007) 1.43

Genetics of schizophrenia: new findings and challenges. Annu Rev Genomics Hum Genet (2011) 1.41

Association of ADH and ALDH genes with alcohol dependence in the Irish Affected Sib Pair Study of alcohol dependence (IASPSAD) sample. Alcohol Clin Exp Res (2008) 1.41

A genome-wide significant linkage for severe depression on chromosome 3: the depression network study. Am J Psychiatry (2011) 1.41

Spontaneous cortical activity alternates between motifs defined by regional axonal projections. Nat Neurosci (2013) 1.41

DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood (2011) 1.40

Correction: Improved Detection of Common Variants Associated with Schizophrenia and Bipolar Disorder Using Pleiotropy-Informed Conditional False Discovery Rate. PLoS Genet (2015) 1.39

A DNA microarray for fission yeast: minimal changes in global gene expression after temperature shift. Yeast (2004) 1.38

Genetic and environmental sources of covariation between generalized anxiety disorder and neuroticism. Am J Psychiatry (2004) 1.37

A longitudinal study of personality and major depression in a population-based sample of male twins. Psychol Med (2007) 1.35

Pathways to cannabis abuse: a multi-stage model from cannabis availability, cannabis initiation and progression to abuse. Addiction (2009) 1.33

The Irish Affected Sib Pair Study of Alcohol Dependence: study methodology and validation of diagnosis by interview and family history. Alcohol Clin Exp Res (2005) 1.33

Genetic and environmental contributions to obesity and binge eating. Int J Eat Disord (2003) 1.33

Candidate genes for schizophrenia: a survey of association studies and gene ranking. Am J Med Genet B Neuropsychiatr Genet (2008) 1.31

AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol Psychiatry (2007) 1.30

A twin study of the genetics of fear conditioning. Arch Gen Psychiatry (2003) 1.30

DSM criteria for major depression: evaluating symptom patterns using latent-trait item response models. Psychol Med (2005) 1.30

Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia. Am J Psychiatry (2003) 1.29

Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. Am J Med Genet B Neuropsychiatr Genet (2003) 1.28

The mu-opioid receptor gene and smoking initiation and nicotine dependence. Behav Brain Funct (2006) 1.28

The subtypes of major depression in a twin registry. J Affect Disord (2002) 1.27

The joint structure of DSM-IV Axis I and Axis II disorders. J Abnorm Psychol (2011) 1.25

DIST: direct imputation of summary statistics for unmeasured SNPs. Bioinformatics (2013) 1.25